Humacyte, Inc. (HUMA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$108.14M | +5.5% |
| 2024 | -$114.40M | -14.3% |
| 2023 | -$100.05M | -18.3% |
| 2022 | -$84.58M | -4.1% |
| 2021 | -$81.21M | -25.7% |
| 2020 | -$64.60M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$108.14M | +5.5% |
| 2024 | -$114.40M | -14.3% |
| 2023 | -$100.05M | -18.3% |
| 2022 | -$84.58M | -4.1% |
| 2021 | -$81.21M | -25.7% |
| 2020 | -$64.60M | — |